Danielle Bradbury

For over 20 years, Danielle Bradbury has been a leader and expert in quality assurance for the pharmaceutical industry. Ms. Bradbury’s in-depth knowledge of drug development was acquired on clinical trials that spanned a diverse range of therapeutics that included small molecules, monoclonal antibodies, and combination drug/device products. Her expertise in global operations and quality assurance spans a broad portfolio of early- and late-stage products developed by companies that include Galera Therapeutics, Inclinica, BTG, Actelion, Johnson and Johnson, and, currently, Mineralys. Prior to joining the industry sector, Ms. Bradbury worked in the field as a clinical trial nurse and served as a member of the Institutional Review Board at the University of Pennsylvania.

Ms. Bradbury received her Bachelor of Science in Nursing from Wilmington University.